Trulieve Cannabis (TRLV) Could Be 39% Undervalued Following Profit Return And DEA Registrations

Simply Wall St.12:47

Trulieve Cannabis earnings and DEA registration shift the conversation Trulieve Cannabis (TRLV) just paired a return to quarterly profitability with fresh DEA registrations for its medical marijuana ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2682032287?lang=en_US&edition=fundamental","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/industry/6121000-choice1-card/1788949577743","is_english":true,"pubTime":"2026-11-11 12:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2682032287","market":"us","top_or_hot":-1,"title":"Trulieve Cannabis (TRLV) Could Be 39% Undervalued Following Profit Return And DEA Registrations","media":"Simply Wall St.","content":"<div>\n<p>Trulieve Cannabis earnings and DEA registration shift the conversation Trulieve Cannabis (TRLV) just paired a return to quarterly profitability with fresh DEA registrations for its medical marijuana ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-trlv/trulieve-cannabis/news/trulieve-cannabis-trlv-could-be-39-undervalued-following-pro\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Trulieve Cannabis (TRLV) Could Be 39% Undervalued Following Profit Return And DEA Registrations</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTrulieve Cannabis (TRLV) Could Be 39% Undervalued Following Profit Return And DEA Registrations\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-11-11 12:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-trlv/trulieve-cannabis/news/trulieve-cannabis-trlv-could-be-39-undervalued-following-pro><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Trulieve Cannabis earnings and DEA registration shift the conversation Trulieve Cannabis (TRLV) just paired a return to quarterly profitability with fresh DEA registrations for its medical marijuana ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-trlv/trulieve-cannabis/news/trulieve-cannabis-trlv-could-be-39-undervalued-following-pro\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DEA","symbol_name":"Easterly Government Properties Inc","start_time":0,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-trlv/trulieve-cannabis/news/trulieve-cannabis-trlv-could-be-39-undervalued-following-pro","article_id":"2682032287","we_media_id":null,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/industry/6121000-choice1-card/1788949577743"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-trlv/trulieve-cannabis/news/trulieve-cannabis-trlv-could-be-39-undervalued-following-pro","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2682032287","pubTimestamp":1794372459,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"SSasha JovanovicNovember 11, 2026","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"DEA":"Easterly Government Properties Inc","MSOS":"AdvisorShares Pure US Cannabis ETF","VOTE":"TCW Transform 500 ETF","VGFPF":"Vanguard Funds PLC","BK4223":"办公室房地产信托","GXDW":"Global X Dorsey Wright Thematic ETF","PMDE":"PGIM S&P 500 Max Buffer ETF - December","DECU":"AllianzIM U.S. Equity Buffer15 Uncapped Dec ETF","TOKE":"Cambria Cannabis ETF","BK4194":"办公房地产投资信托","MJ":"Amplify Alternative Harvest ETF","JOYT":"JPMorgan Equity and Options Total Return ETF","BK4007":"制药","CNBS":"Amplify Seymour Cannabis ETF","WEED":"Roundhill Cannabis ETF","TRLV":"Trulieve Cannabis Corporation","FEBU":"AllianzIM U.S. Equity Buffer15 Uncapped Feb ETF","MSOX":"AdvisorShares MSOX 2X Daily ETF","YOLO":"AdvisorShares Pure Cannabis ETF","RGLO":"Global Equity Active ETF"},"translate_title":"Trulieve Cannabis (TRLV) 在利润回报和 DEA 注册后可能被低估 39%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MJ":1.5,"RGLO":0.65,"VOTE":0.65,"CNBS":1.5,"PMDE":0.65,"JOYT":0.65,"WEED":1.5,"DEA":1.5,"VGFPF":0.65,"TRLV":1.5,"MSOS":1.5,"FEBU":0.65,"TOKE":1.5,"MSOX":1.5,"YOLO":1.5,"GXDW":0.65,"DECU":0.65},"content_text":"Trulieve Cannabis earnings and DEA registration shift the conversation Trulieve Cannabis (TRLV) just paired a return to quarterly profitability with fresh DEA registrations for its medical marijuana dispensaries, reshaping how investors may think about both its earnings profile and regulatory footing. Trulieve Cannabis has seen momentum build over 2026, with a 1-year total shareholder return of 59.8% and a year to date share price return of 27.47% despite a softer 7 day share price move. That upswing has coincided with the DEA registration news and the third quarter swing back into quarterly profit. Scan for other cannabis and healthcare operators showing similar earnings and regulatory momentum by checking the hand picked 36 healthcare AI stocks that could sit alongside Trulieve Cannabis in a watchlist. Trulieve Cannabis now trades at a steep discount to both analyst targets and intrinsic value estimates after this DEA backed rally. Is that a mispricing, or is the market putting a lid on regulatory and earnings risk? AdvertisementMost Popular Narrative: 39% Undervalued On the analyst consensus Narrative on Simply Wall St, Trulieve Cannabis screens as undervalued, with a fair value of $18.18 against the recent $11.09 close. This puts the DEA registration news into a much bigger earnings and tax story. Federal reclassification of medical marijuana to Schedule III, along with the ability to register with the DEA and deduct ordinary expenses, is expected to reduce the impact of 280E and could free up more cash to support earnings and operating margins over time. See why 8 investors see Trulieve Cannabis as 39% undervalued. Result: Fair Value of $18.18 (UNDERVALUED) Still, the bullish Trulieve Cannabis narrative depends heavily on smooth federal rescheduling and tax outcomes, while pricing pressure and softer consumer spending could undercut those expectations. Find out about the key risks to this Trulieve Cannabis narrative. Next Steps Mixed signals on Trulieve Cannabis so far, so do not let the headline sentiment make the decision for you when the data is this split. Take a few minutes to weigh both sides of the story by reviewing the 3 key rewards and 1 important warning sign. Looking for more Trulieve Cannabis style ideas? If you only stop at Trulieve Cannabis, you could miss opportunities that better match your risk tolerance, time horizon, and income goals across the market.  Target potential mispricings by scanning a curated set of value candidates through the 35 high quality undervalued stocks. Build resilience into your portfolio by focusing on companies with strong finances using the list of solid balance sheet and fundamentals (24 results). Hunt for lesser known opportunities with quality fundamentals through the 20 high quality undiscovered gems.  This article is general in nature and was produced with the assistance of AI automation,\n        based on data and analysis from Simply Wall St. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.Valuation is complex, but we're here to simplify it.Discover if Trulieve Cannabis might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2682032287","isCrawlerRequest":true}